Agilent Technologies (NYSE:A) Director Sells $95,974.92 in Stock

Agilent Technologies, Inc. (NYSE:A) Director Mikael Dolsten sold 634 shares of the firm’s stock in a transaction on Friday, September 4th. The stock was sold at an average price of $151.38, for a total value of $95,974.92. Following the completion of the sale, the director directly owned 4,924 shares of the company’s stock, valued at $745,395.12. This represents a 11.41% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Agilent Technologies Stock Performance

Shares of A opened at $146.91 on Friday. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $163.75. The company has a debt-to-equity ratio of 0.50, a current ratio of 2.05 and a quick ratio of 1.56. The stock’s fifty day moving average price is $143.71 and its two-hundred day moving average price is $128.62. The firm has a market cap of $41.42 billion, a PE ratio of 28.92, a PEG ratio of 2.18 and a beta of 1.24.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, August 26th. The medical research company reported $1.62 earnings per share for the quarter, topping the consensus estimate of $1.49 by $0.13. Agilent Technologies had a return on equity of 24.45% and a net margin of 19.53%.The company had revenue of $1.88 billion during the quarter, compared to the consensus estimate of $1.84 billion. During the same quarter in the prior year, the company earned $1.37 EPS. The firm’s quarterly revenue was up 8.1% compared to the same quarter last year. Agilent Technologies has set its Q4 2026 guidance at 1.710-1.740 EPS and its FY 2026 guidance at 6.180-6.210 EPS. On average, equities research analysts forecast that Agilent Technologies, Inc. will post 6.2 EPS for the current year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Core Wealth Advisors LLC bought a new position in shares of Agilent Technologies in the fourth quarter worth $26,000. SHP Wealth Management bought a new stake in Agilent Technologies during the fourth quarter valued at $26,000. Navalign LLC purchased a new position in Agilent Technologies during the fourth quarter worth about $27,000. Cedar Mountain Advisors LLC bought a new position in Agilent Technologies in the 1st quarter worth about $27,000. Finally, Markowski Investments bought a new position in Agilent Technologies in the 2nd quarter worth about $27,000. 87.41% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities analysts have recently weighed in on the stock. Jefferies Financial Group began coverage on shares of Agilent Technologies in a research note on Thursday, July 9th. They issued a “hold” rating and a $135.00 target price for the company. Sanford C. Bernstein upped their price target on shares of Agilent Technologies from $155.00 to $180.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Robert W. Baird raised their price objective on shares of Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a report on Tuesday, May 26th. Royal Bank Of Canada lifted their price objective on shares of Agilent Technologies from $155.00 to $185.00 and gave the company an “outperform” rating in a research note on Thursday, August 27th. Finally, HSBC lowered their target price on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. One analyst has rated the stock with a Strong Buy rating, fourteen have given a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, Agilent Technologies has an average rating of “Moderate Buy” and an average price target of $170.33.

About Agilent Technologies

Agilent Technologies, Inc is a global provider of analytical instruments, laboratory software, consumables and services used by organizations in the life sciences, diagnostics, pharmaceutical, chemical, environmental and food industries. Its solutions help customers analyze the composition and quality of substances, develop and manufacture products, and conduct research and testing.

The company’s offerings include liquid and gas chromatography systems, mass spectrometry instruments, spectroscopy and atomic analysis equipment, automated electrophoresis systems, laboratory informatics software, columns and other consumables.